Trial · NCT00929253
Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
NCT00929253, Not applicable, Completed, Virginia Polytechnic Institute and State University; results first posted 2022-05-27
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II). Trials, record NCT00929253. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00929253
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
- NCT number
- NCT00929253
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 170 participants, actual
- Lead sponsor
- Virginia Polytechnic Institute and State University
- Conditions
- Opiate Addiction
- Interventions
- Suboxone, CRA, Therapy, CM
- First posted
- 2009-06-29
- Last updated
- 2022-05-27
- Results first posted
- 2022-05-27
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Abstinence | 12 weeks | Abstinence defined as the longest documented period of continuous abstinence from opioids and cocaine |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Abstinence | 12 weeks | days | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Abstinence | Computer Delivered CRA + CM + Suboxone | 55.0 | Standard Deviation 26.2 | days | |
| Abstinence | CM + Suboxone | 49.5 | Standard Deviation 30.6 | days |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Computer Delivered CRA + CM + Suboxone | 91 | |
| Overall Study | STARTED | CM + Suboxone | 79 | |
| Overall Study | COMPLETED | Computer Delivered CRA + CM + Suboxone | 91 | |
| Overall Study | COMPLETED | CM + Suboxone | 79 | |
| Overall Study | NOT COMPLETED | Computer Delivered CRA + CM + Suboxone | 0 | |
| Overall Study | NOT COMPLETED | CM + Suboxone | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | adverse event | General disorders | Computer Delivered CRA + CM + Suboxone | 57 | 91 | 147 |
| other | adverse event | General disorders | CM + Suboxone | 55 | 79 | 113 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Computer Delivered CRA + CM + Suboxone | ||
| Total, all-cause mortality | CM + Suboxone | ||
| Total, other adverse events | Computer Delivered CRA + CM + Suboxone | 57 | 91 |
| Total, other adverse events | CM + Suboxone | 55 | 79 |
| Total, serious adverse events | Computer Delivered CRA + CM + Suboxone | 0 | 91 |
| Total, serious adverse events | CM + Suboxone | 0 | 79 |
Source ClinicalTrials.gov
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Computer Delivered CRA + CM + Suboxone vs CM + Suboxone: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00929253
GET https://conductscience.org/api/trials/v1/NCT00929253/registered